Connection
Lisa Brents to Substance-Related Disorders
This is a "connection" page, showing publications Lisa Brents has written about Substance-Related Disorders.
|
|
Connection Strength |
|
|
|
|
|
0.838 |
|
|
|
-
Tobacyk J, Parks BJ, Lovelady N, Brents LK. Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom. Int J Drug Policy. 2022 10; 108:103817.
Score: 0.547
-
Brents LK, Zimmerman SM, Saffell AR, Prather PL, Fantegrossi WE. Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy. J Pharmacol Exp Ther. 2013 Sep; 346(3):350-61.
Score: 0.291